About
Drug Development
Areas of Focus
Categories
Contract ResearchSan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
0
As Collaborator
4
Total Enrollment
627
By Phase
PHASE3: 1PHASE1: 1PHASE2: 2
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT00477282Collaborator
Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
PHASE3Completed
509 participants
Started: Aug 31, 2007 · Completed: Jun 30, 2013
NCT00097903Collaborator
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer
PHASE1Completed
32 participants
Started: May 31, 2004 · Completed: May 31, 2013
NCT00062491Collaborator
Study of Karenitecin (BNP1350) to Treat Malignant Melanoma
PHASE2Completed
46 participants
Started: May 31, 2002 · Completed: Nov 30, 2005
NCT00062478Collaborator
Study of Karenitecin (BNP1350) in Patients With Brain Tumors
PHASE2Completed
40 participants
Started: Oct 31, 2001
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...